Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Microglial-neuronal interactions are essential for brain physiopathology. In this framework, recent data have changed the concept of microglia from essentially macrophagic cells to crucial elements in maintaining neuronal homeostasis and function through the release of neuroprotective molecules. Using proteomic analysis, here we identify copper-zinc superoxide dismutase (SOD1) as a protein produced and released by cultured rat primary microglia. Evidence for a neuroprotective role of microglia-derived SOD1 resulted from experiments in which primary cerebellar granule neurons (CGNs) were exposed to the dopaminergic toxin 6-hydroxydopamine (6-OHDA). Microglial conditioned medium, in which SOD1 had accumulated, protected CGNs from degeneration, and neuroprotection was abrogated by SOD1 inhibitors. These effects were replicated when exogenous SOD1 was added to a nonconditioned medium. SOD1 neuroprotective action was mediated by increased cell calcium from an external source. Further experiments demonstrated the specificity of SOD1 neuroprotection against 6-OHDA compared to other types of neurotoxic challenges. SOD1, constitutively produced and released by microglia through a lysosomal secretory pathway, is identified here for the first time as an essential component of neuroprotection mediated by microglia. This novel information is relevant to stimulating further studies of microglia-mediated neuroprotection in in vivo models of neurodegenerative diseases.

[1]  P. Monk,et al.  A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function , 2011, BMC Neuroscience.

[2]  H. Gendelman,et al.  Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells. , 2011, Nanomedicine.

[3]  S. Appel,et al.  The Microglial-Motoneuron dialogue in ALS , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[4]  Inbal Goshen,et al.  Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.

[5]  M. Graeber Changing Face of Microglia , 2010, Science.

[6]  E. Polazzi,et al.  Microglia and neuroprotection: From in vitro studies to therapeutic applications , 2010, Progress in Neurobiology.

[7]  M. A. Ajmone-Cat,et al.  TGF‐β and LPS modulate ADP‐induced migration of microglial cells through P2Y1 and P2Y12 receptor expression , 2010, Journal of neurochemistry.

[8]  Shijie Jin,et al.  Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway , 2010, Brain Research.

[9]  E. Ling,et al.  NG2, a member of chondroitin sulfate proteoglycans family mediates the inflammatory response of activated microglia , 2010, Neuroscience.

[10]  S. Traynelis,et al.  Differential regulation of microglial motility by ATP/ADP and adenosine. , 2009, Parkinsonism & related disorders.

[11]  Weihua Zhao,et al.  Microglia in ALS: The Good, The Bad, and The Resting , 2009, Journal of Neuroimmune Pharmacology.

[12]  W. Streit,et al.  Life and Death of Microglia , 2009, Journal of Neuroimmune Pharmacology.

[13]  Robert A. Smith,et al.  Xanthine oxidase-induced neuronal death via the oxidation of NADH: Prevention by micromolar EDTA , 2009, Brain Research.

[14]  D. Kirik,et al.  Scientific rationale for the development of gene therapy strategies for Parkinson's disease. , 2009, Biochimica et biophysica acta.

[15]  A. Contestabile,et al.  Neuroprotection of microglial conditioned medium on 6‐hydroxydopamine‐induced neuronal death: role of transforming growth factor beta‐2 , 2009, Journal of neurochemistry.

[16]  H. Gendelman,et al.  Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. , 2009, Journal of proteome research.

[17]  Chunfu Wu,et al.  Pretreatment with interferon-gamma protects microglia from oxidative stress via up-regulation of Mn-SOD. , 2009, Free radical biology & medicine.

[18]  J. Nabekura,et al.  Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals , 2009, The Journal of Neuroscience.

[19]  S. Sugama,et al.  The Activation of P2X7 Receptor Impairs Lysosomal Functions and Stimulates the Release of Autophagolysosomes in Microglial Cells1 , 2009, The Journal of Immunology.

[20]  O. Lindvall,et al.  Brain inflammation and adult neurogenesis: The dual role of microglia , 2009, Neuroscience.

[21]  H. Neumann,et al.  Microglial clearance function in health and disease , 2009, Neuroscience.

[22]  A. Contestabile,et al.  Neuroprotection of microglia conditioned media from apoptotic death induced by staurosporine and glutamate in cultures of rat cerebellar granule cells , 2008, Neuroscience Letters.

[23]  Feng Ding,et al.  Dynamical roles of metal ions and the disulfide bond in Cu, Zn superoxide dismutase folding and aggregation , 2008, Proceedings of the National Academy of Sciences.

[24]  A. Secondo,et al.  The Cu-Zn superoxide dismutase (SOD1) inhibits ERK phosphorylation by muscarinic receptor modulation in rat pituitary GH3 cells. , 2008, Biochemical and biophysical research communications.

[25]  Robert A. Smith,et al.  Prolonged exposures of cerebellar granule neurons to S-nitroso-N-acetylpenicillamine (SNAP) induce neuronal damage independently of peroxynitrite , 2008, Brain Research.

[26]  Kazuhide Inoue,et al.  Purinergic systems in microglia , 2008, Cellular and Molecular Life Sciences.

[27]  Yaniv Ziv,et al.  Immunity to self and self-maintenance: what can tumor immunology teach us about ALS and Alzheimer's disease? , 2008, Trends in pharmacological sciences.

[28]  Shengdi Chen,et al.  Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. , 2008, Journal of proteome research.

[29]  D. Cleveland,et al.  Revisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1. , 2008, The Journal of clinical investigation.

[30]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[31]  A. Contestabile,et al.  Alpha‐synuclein protects cerebellar granule neurons against 6‐hydroxydopamine‐induced death , 2007, Journal of neurochemistry.

[32]  F. Benfenati,et al.  Evidence of calcium‐ and SNARE‐dependent release of CuZn superoxide dismutase from rat pituitary GH3 cells and synaptosomes in response to depolarization , 2007, Journal of neurochemistry.

[33]  Robert A. Smith,et al.  Hydrogen peroxide mediates damage by xanthine and xanthine oxidase in cerebellar granule neuronal cultures , 2007, Neuroscience Letters.

[34]  H. Gendelman,et al.  Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation , 2007, Journal of neurochemistry.

[35]  D. Steindler,et al.  Microglia instruct subventricular zone neurogenesis , 2006, Glia.

[36]  S. Mckercher,et al.  Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis , 2006, Proceedings of the National Academy of Sciences.

[37]  A. English,et al.  Binding of polyaminocarboxylate chelators to the active-site copper inhibits the GSNO-reductase activity but not the superoxide dismutase activity of Cu,Zn-superoxide dismutase. , 2006, Biochemistry.

[38]  Shigetada Nakanishi,et al.  Membrane potential‐regulated Ca2+ signalling in development and maturation of mammalian cerebellar granule cells , 2006, The Journal of physiology.

[39]  D. Shaw,et al.  Copper Binding by Tetrathiomolybdate Attenuates Angiogenesis and Tumor Cell Proliferation through the Inhibition of Superoxide Dismutase 1 , 2006, Clinical Cancer Research.

[40]  Michal Schwartz,et al.  Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Kollias,et al.  Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.

[42]  K. Reymann,et al.  Microglia provide neuroprotection after ischemia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  I. Hinners,et al.  System Xc− and Apolipoprotein E Expressed by Microglia Have Opposite Effects on the Neurotoxicity of Amyloid-β Peptide 1–40 , 2006, The Journal of Neuroscience.

[44]  Michal Schwartz,et al.  Microglial phenotype: is the commitment reversible? , 2006, Trends in Neurosciences.

[45]  W. Hwang,et al.  Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing. , 2005, Journal of biotechnology.

[46]  M. Schwartz,et al.  T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure , 2005, Journal of Molecular Medicine.

[47]  J. Valentine,et al.  Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. , 2005, Annual review of biochemistry.

[48]  T. Möller,et al.  Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.

[49]  R. Simone,et al.  Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation , 2005, Brain Research Reviews.

[50]  A. Hill,et al.  Impaired Extracellular Secretion of Mutant Superoxide Dismutase 1 Associates with Neurotoxicity in Familial Amyotrophic Lateral Sclerosis , 2005, The Journal of Neuroscience.

[51]  P. Formisano,et al.  Cu,Zn superoxide dismutase increases intracellular calcium levels via a phospholipase C-protein kinase C pathway in SK-N-BE neuroblastoma cells. , 2004, Biochemical and biophysical research communications.

[52]  M. Schwartz,et al.  A common vaccine for fighting neurodegenerative disorders: recharging immunity for homeostasis. , 2004, Trends in pharmacological sciences.

[53]  Andrew J. Crossthwaite,et al.  Expression of SOD1 G93A or wild‐type SOD1 in primary cultures of astrocytes down‐regulates the glutamate transporter GLT‐1: lack of involvement of oxidative stress , 2003, Journal of neurochemistry.

[54]  E. Yoles,et al.  Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Greco,et al.  The Cu,Zn superoxide dismutase in neuroblastoma SK-N-BE cells is exported by a microvesicles dependent pathway. , 2003, Brain research. Molecular brain research.

[56]  T. Mariani,et al.  Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. , 2002, Free radical biology & medicine.

[57]  E. García-Martín,et al.  Inhibition of oxidative stress produced by plasma membrane NADH oxidase delays low‐potassium‐induced apoptosis of cerebellar granule cells , 2002, Journal of neurochemistry.

[58]  J. Mallet,et al.  Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6‐hydroxydopamine , 2002, Journal of neurochemistry.

[59]  P. Mondola,et al.  CuZn-superoxide dismutase in human thymus: immunocytochemical localisation and secretion in thymus-derived epithelial and fibroblast cell lines , 2002, Histochemistry and Cell Biology.

[60]  K. Unsicker,et al.  TGF-β and the regulation of neuron survival and death , 2002, Journal of Physiology-Paris.

[61]  J. Calafat,et al.  Specific granules of human eosinophils have lysosomal characteristics: presence of lysosome-associated membrane proteins and acidification upon cellular activation. , 2002, Biochemical and biophysical research communications.

[62]  A. Contestabile,et al.  Microglial cells protect cerebellar granule neurons from apoptosis: Evidence for reciprocal signaling , 2001, Glia.

[63]  Hui Zhang,et al.  Co-culture with astrocytes or microglia protects metabolically impaired neurons , 2001, Mechanisms of Ageing and Development.

[64]  R. Gold,et al.  Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation1 , 2001, The Journal of Immunology.

[65]  K. Suzuki,et al.  Comparative mechanism and toxicity of tetra- and dithiomolybdates in the removal of copper. , 1999, Journal of inorganic biochemistry.

[66]  M. Sakanaka,et al.  Microglial cells prevent nitric oxide‐induced neuronal apoptosis in vitro , 1998, Journal of neuroscience research.

[67]  S. Budd,et al.  Mitochondria and neuronal glutamate excitotoxicity. , 1998, Biochimica et biophysica acta.

[68]  M. Santillo,et al.  Secretion and Increase of Intracellular CuZn Superoxide Dismutase Content in Human Neuroblastoma SK-N-BE Cells Subjected to Oxidative Stress , 1998, Brain Research Bulletin.

[69]  M. Ciotti,et al.  Glutamate Neurotoxicity in Rat Cerebellar Granule Cells: A Major Role for Xanthine Oxidase in Oxygen Radical Formation , 1997, Journal of neurochemistry.

[70]  M. Santillo,et al.  Evidence for secretion of cytosolic CuZn superoxide dismutase by Hep G2 cells and human fibroblasts. , 1996, The international journal of biochemistry & cell biology.

[71]  J. Borowitz,et al.  NMDA Receptor Activation Produces Concurrent Generation of Nitric Oxide and Reactive Oxygen Species: Implications for Cell Death , 1995, Journal of neurochemistry.

[72]  A. Privat,et al.  Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures , 1994, Journal of neuroscience research.

[73]  M. Santillo,et al.  The calf superoxide dismutase receptor of rat hepatocytes. , 1994, Comparative biochemistry and physiology. Biochemistry and molecular biology.

[74]  H. Saito,et al.  Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain , 1993, Journal of neuroscience research.

[75]  S. Marklund Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. , 1992, The Journal of biological chemistry.

[76]  S. Marklund Expression of extracellular superoxide dismutase by human cell lines. , 1990, The Biochemical journal.

[77]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[78]  R. Balázs,et al.  The role of depolarization in the survival and differentiation of cerebellar granule cells in culture , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[79]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[80]  J. Perez-polo,et al.  Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line. , 1982, Biochemical pharmacology.

[81]  H. Forman,et al.  Mechanism for the potentiation of oxygen toxicity by disulfiram. , 1980, The Journal of pharmacology and experimental therapeutics.

[82]  R. Heikkila,et al.  The stimulation of 6-hydroxydopamine autoxidation by bivalent copper: potential importance in the neurotoxic process. , 1978, Life sciences.

[83]  M. Schwartz,et al.  Butovsky, O. et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl Acad. Sci. USA 103, 11784-11789 , 2006 .

[84]  T. Möller,et al.  Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. , 2005, Journal of immunology.

[85]  A. Contestabile,et al.  Reciprocal Interactions Between Microglia and Neurons: From Survival to Neuropathology , 2002, Reviews in the neurosciences.

[86]  K. Unsicker,et al.  TGF-beta and the regulation of neuron survival and death. , 2002, Journal of physiology, Paris.

[87]  K. Nagata,et al.  Plasminogen mediates an interaction between microglia and dopaminergic neurons. , 1994, European Neurology.